This inventor holds 3 USPTO granted patents. Top assignee: University of Florida Research Foundation Inc.. Active years: 2000-2007.
Company Filing History:
Years Active: 2000-2007
Title: Innovations by Mustafa G Mujtaba
Introduction
Mustafa G Mujtaba is an accomplished inventor based in Gainesville, FL (US). He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic methods for treating various diseases. With a total of 3 patents, his work focuses on innovative approaches to combat inflammatory disorders and cancer.
Latest Patents
One of Mujtaba's latest patents involves inhibitors of autophosphorylation protein kinases. This invention concerns peptide molecules that specifically inhibit the enzymatic function of tyrosine kinases, including the JAK and EGF receptor (EGFR) family of kinases. The invention aims to inhibit the autophosphorylation process, which is crucial for signal transduction among proteins in a cell. By inhibiting tyrosine kinase autophosphorylation activities, the signaling pathways originating from these enzymes can be shut down, which is particularly relevant in inflammatory disorders and cancer where these kinases may be activated uncontrollably. Additionally, the patent includes antibodies that bind to a tyrosine kinase autophosphorylation site and pharmaceutically acceptable formulations for treating these conditions.
Another significant patent pertains to novel methods for treating autoimmune-related diseases, such as Multiple Sclerosis (MS). This method involves administering interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β) in combination to individuals afflicted with or predisposed to autoimmune diseases. The synergistic action of these cytokines serves as suppressor factors to inhibit the activation of self-reactive T cells involved in autoimmune responses.
Career Highlights
Mujtaba is affiliated with the University of Florida Research Foundation Inc., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on therapeutic strategies for complex diseases.
Collaborations
He has collaborated with notable colleagues, including Howard Marcellus Johnson and Jeanne M Soos, contributing to a rich environment of innovation and research.
Conclusion
Mustafa G Mujtaba's contributions to the field of biomedical research through his patents and innovative methods highlight his commitment to addressing critical health challenges. His work continues to pave the way for advancements in treatment options for inflammatory disorders and cancer.